Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACE-MDS: Luspatercept for Anemia in Low/Intermediate-1 Risk MDS
NCT01749514Phase 2Completed
- Start
- Jan 2013
- Primary completion
- Oct 2018
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of luspatercept in anemia. Started Jan 2013; status: completed.
02
Drugs
luspatercept
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01749514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749514.